Autopsy report · NCT06699160

Refobacin Revision-3 Bone Cement Post-Market Study

“The study was discontinued upon availability of relevant data through bespoke reporting, which fulfilled the study's primary objectives”

The sponsor’s own words in the registry.

Life of this trial

• Withdrawn before it enrolled anyone. Its dates are the sponsor's plans, not events that happened.

Vital statistics

Status

Withdrawn

Sponsor

Zimmer Biomet

Sponsor type

Industry

Conditions

Revision Arthroplasty

Interventions

Revision arthroplasty

Participants

0

Sites

1

Countries

Netherlands

Trials that died the same way

• GSK1572932A Antigen-Specific Cancer Immunotherapeutic as Adjuvant Therapy in Patients With Non-Small Cell Lung Cancer
  “The study was terminated following assessment of the lack of efficacy of the study product by the Independent Data monitoring Committee for the study.” (72% match in meaning)
• Assessment Of Disease Pathology And Key Therapeutic Targets In Severe Asthma
  “The study was truncated due to the long period of enrollment and the collection of a sufficient amount of data that allowed the scientific objectives to be met” (70% match in meaning)
• Magrolimab + Azacitidine Versus Azacitidine + Placebo in Untreated Participants With Myelodysplastic Syndrome (MDS)
  “Study discontinued due to futility based on a planned analysis” (69% match in meaning)
• Javelin BRCA/ATM: Avelumab Plus Talazoparib in Patients With BRCA or ATM Mutant Solid Tumors
  “The study was terminated since there was no need for further safety or efficacy data to be collected. The participants having benefit from the investigational treatments have been moved to a continuation study (NCT05059522)” (68% match in meaning)
• A Study Of PF-06664178 In Patients With Advanced Solid Tumors
  “The study was prematurely discontinued due to a business-related decision on 09-FEB-2016. The decision to terminate the trial was based on the overall results.” (67% match in meaning)

Look deeper

• The official registry record (the source of truth)
• Record history: every change the sponsor made
• Open it in the database

Everything here comes from the current ClinicalTrials.gov record. The timeline uses the record’s dates; dates marked planned are the sponsor’s plans. The cause of death is an automatic, unverified label. This is research information, not medical advice.